The use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubility.

The present study investigates the release mechanism of benznidazole (BNZ) in solid dispersions with polyethylene glycol 6000 (PEG 6000) and polyvinylpirrolydone K-30 (PVP K-30), with a view to observing the increase in solubility of BNZ in water in the presence of these two hydrophilic polymers. The interaction of BNZ with the polymers was evaluated using scanning electron microscopy, Fourier-transformation infrared spectroscopy, differential scanning calorimetry, X-ray diffraction, and in vitro dissolution tests, and a theoretical study of molecular modeling was also carried out. The drug-polymer interaction was studied trough molecular modeling, using density functional theory with the B3LYP exchange correlation function. The corrected interaction energies were calculated to be -20.9 kJ/mol with PVP and -6.6 kJ/mol with PEG. The experimental and theoretical results indicate that a powerful interaction occurred between BNZ and the polymers, which was especially strong in the case of PVP, and that this interaction contributed to improvement of BNZ solubility.

[1]  M. Soares,et al.  Development and in vitro evaluation of tablets based on the antichagasic benznidazole , 2008 .

[2]  J. Coura,et al.  A critical review on Chagas disease chemotherapy. , 2002 .

[3]  E. Serra,et al.  Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. , 2006, International journal of pharmaceutics.

[4]  R. Bestetti,et al.  Sudden cardiac death in Chagas' heart disease in the contemporary era. , 2008, International journal of cardiology.

[5]  A. Hedges Industrial Applications of Cyclodextrins. , 1998, Chemical reviews.

[6]  Ginés Sanz,et al.  Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica , 2007 .

[7]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[8]  S. Okonogi,et al.  Dissolution improvement of high drug-loaded solid dispersion , 2006, AAPS PharmSciTech.

[9]  R. Docampo Recent developments in the chemotherapy of Chagas disease. , 2001, Current pharmaceutical design.

[10]  G. Sanz,et al.  [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic]. , 2008, Enfermedades infecciosas y microbiologia clinica.

[11]  M. Miles,et al.  Trypanosoma cruzi in Brazilian Amazonia: Lineages TCI and TCIIa in wild primates, Rhodnius spp. and in humans with Chagas disease associated with oral transmission. , 2009, International journal for parasitology.

[12]  S. F. Boys,et al.  The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .

[13]  Keiji Sekiguchi,et al.  Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .